DD vs EW · P/E 127, rev $12.39B vs P/E 47, rev $1.39B
Dupont De Nemours Inc (DD) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
DD currently screens at market cap $19.61B and trailing P/E 127.4. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the DD and EW stock pages for the full models.
Not investment advice.